Abidjan, Cote d’Ivoire, 27 June 2014 : Cauris Croissance, the second fund managed by Cauris Management, the West African private equity fund manager, announced that it has successfully exited its investment in MTN-CI. The investment was made in 2009 via PCI, a Mauritian SPV and total proceeds represented over 2.5x the fund’s initial investment.
FONDS CAURIS CROISSANCE II INVESTS IN CIPHARM
Abidjan, Cote d’Ivoire, April 2014: FONDS CAURIS CROISSANCE II LIMITED, advised by Cauris Management, the West African fund manager agreed to invest in CIPHARM to fund a new production line for injectable pharmaceutical products.
CIPHARM is a Cote d’Ivoire-based leading pharmaceutical company with revenues derived from 12 countries across west and central Africa. The company has been in operations for over 25 years and manufactures a broad range of generic pharmaceuticals (dry forms, syrups and powder) under its own brand names as well as licensed names. Lire la suite de l'article
CAURIS MANAGEMENT SIGNS A PARTNERSHIP AGREEMENT WITH THE BRVM
Cauris Management, entered into a partnership agreement with “Bourse Régionale des Valeurs Mobilières (BRVM)”. This partnership will allow both institutions to share their experiences and to develop synergies in the financing of SMEs and companies with high growth potential and the creation of the new board dedicated to SMEs. Indeed, access to finance remains a major concern for SMEs in the WAEMU. Lire la suite de l'article